Lonza is expanding its partnership with an undisclosed major pharmaceutical company to supply antibody-drug conjugates (ADCs). This agreement includes building a new facility at Lonza’s Ibex® Biopark in Visp (Valais), Switzerland, and providing large-scale production of monoclonal antibodies for a new ADC treatment.
From lab bench to pitch perfection : Ninsun’s cancer-fighting innovation just lit up the Innothèque at Foire du Valais last Friday for the Startup Pitch of the Fondation the Ark !
The “Innovation in the vineyards” event, held on September 30th at the Innothèque space during the Foire du Valais, was a resounding success, attracting over thirty participants. Organized in collaboration with PhytoArk, this event highlighted the technological advancements and innovations transforming the viticulture sector.
On 23 September 2024, ten23 health celebrated the inauguration of its VIVA2® facility in Visp, in the vicinity of our BioArk Visp technology site, bringing to fruition an ambitious project announced in June 2022. This new state-of-the-art infrastructure considerably strengthens the region’s production capacity for sterile medicines.
Swiss contract development and manufacturing organization ten23health has achieved B Corp certification, recognizing its commitment to social and environmental responsibility in the pharmaceutical industry.
Since its launch in 2006, Valais-based Lugaia has gone from strength to strength. It has now established itself as a major player in the global market for containment solutions. Company owner Viktor Schnyder explains what makes Lugaia tick and how the company benefits from its location in the Valais. Lugaia has a history stretching back …
Valaisan SME Lugaia rides the wave of success with its niche products Read More »
We’re thrilled to announce that CEIDOS, a start-up, based at our BioArk Monthey technology site, has just been endorsed by the Innosuisse Innovation Council, securing significant funding! With a total budget of 1.2 million francs, their C-Netics technology will be enhanced in partnership with CSEM and HES-SO Valais-Wallis. This project will perfect their online monitoring …
CEIDOS secures support from Innosuisse in partnership with CSEM & HES-SO Valais-Wallis Read More »
Support innovation in Switzerland by voting for these promising life sciences startups from the Valais region. A strong contingent of 27 startups from the Swiss canton of Valais are competing in the prestigious TOP 100 Swiss Startup Award 2024, showcasing the region’s thriving life sciences ecosystem. Many of these startups, including CEIDOS, GaDia, Orio Therapeutics, …
Valais Startups Shine in the TOP 100 Swiss Startup Award 2024 Read More »
EPFL expands its “Les sciences, ça m’intéresse!” program to Valais, offering engaging science activities for children aged 7 to 16.
The young company Curio Biotech uses human tissue to test cosmetic products and medicines. Thanks to its innovative working method, the company is helping to reduce the number of animal experiments. The company’s founder, Chennakesava Cuddapah, sees great potential in Curio Biotech’s field of activity. In this interview, he gives us a look behind the …
Curio Biotech : A start-up in Visp makes animal testing redundant Read More »
Sion Site
Rue de l’Industrie 23
CH-1950 Sion
Tél. +41 (0) 58 332 21 20
info@bioark.ch
Monthey Site
Rte de l’Ile-au-bois 1A
CH-1870 Monthey
Tél. +41 (0) 58 332 21 20
info@bioark.ch
Massimo Nobile
| BioArk | Book a meeting room
